Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA1650624
Max Phase: Preclinical
Molecular Formula: C8H11NOS
Molecular Weight: 169.25
Molecule Type: Small molecule
Associated Items:
ID: ALA1650624
Max Phase: Preclinical
Molecular Formula: C8H11NOS
Molecular Weight: 169.25
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CCn1ccc(=S)c(O)c1C
Standard InChI: InChI=1S/C8H11NOS/c1-3-9-5-4-7(11)8(10)6(9)2/h4-5,10H,3H2,1-2H3
Standard InChI Key: XTMONGQRZFRDAJ-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 169.25 | Molecular Weight (Monoisotopic): 169.0561 | AlogP: 2.25 | #Rotatable Bonds: 1 |
Polar Surface Area: 25.16 | Molecular Species: NEUTRAL | HBA: 3 | HBD: 1 |
#RO5 Violations: 0 | HBA (Lipinski): 2 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: 13.52 | CX Basic pKa: | CX LogP: 1.86 | CX LogD: 1.86 |
Aromatic Rings: 1 | Heavy Atoms: 11 | QED Weighted: 0.65 | Np Likeness Score: -0.86 |
1. Jacobsen JA, Fullagar JL, Miller MT, Cohen SM.. (2011) Identifying chelators for metalloprotein inhibitors using a fragment-based approach., 54 (2): [PMID:21189019] [10.1021/jm101266s] |
2. Garner AL, Struss AK, Fullagar JL, Agrawal A, Moreno AY, Cohen SM, Janda KD.. (2012) 3-Hydroxy-1-alkyl-2-methylpyridine-4(1H)-thiones: Inhibition of the Pseudomonas aeruginosa Virulence Factor LasB., 3 (8): [PMID:23181168] [10.1021/ml300128f] |
3. Lin, Lucy, Turner, Lewis D., silhar, Peter, Pellett, Sabine, Johnson, Eric A., Janda, Kim D.. (2021) Identification of 3-hydroxy-1,2-dimethylpyridine-4(1H)-thione as a metal-binding motif for the inhibition of botulinum neurotoxin A, 12 (1): [PMID:34046606] [10.1039/d0md00320d] |
Source(1):